Stay updated with breaking news from Evidence Based Care. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The REDUCE-AMI trial found that long-term beta-blocker therapy does not reduce mortality risk in acute myocardial infarction patients with preserved left ventricular ejection fraction compared to no beta-blocker treatment.
KANSAS CITY, MO / ACCESSWIRE / February 29, 2024 / Black Book Research announced that Netsmart has swept the physical therapy technology platform ratings for highest customer satisfaction in the annual client experience polling of 20 top competitors. Nine hundred forty-two physicians, clinicians, and specialists, as...
/PRNewswire/ -- The Newborn Essential Solutions and Technologies (NEST360) international alliance today launches Phase 2 of its groundbreaking mission to...
<p>The Newborn Essential Solutions and Technologies (NEST360) international alliance launches Phase 2 of its mission to reduce newborn mortality in sub-Saharan Africa with $65 million in funding from the Bill & Melinda Gates Foundation, the Children’s Investment Fund Foundation, The ELMA Foundation, and generous individual contributions.</p>
